Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Carvedilol 6.25 mg Tablets: Dilatrend vs Carvolol in Healthy Thai Volunteers
TCTR20170119001Completed
- Sponsor
- Government Pharmaceutical Organization
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol (2 arms), sponsored by Government Pharmaceutical Organization. Primary endpoint: Bioequivalence based on pharmacokinetic parameters. Started May 2017; status: completed.
02
Drugs
carvedilol
Beyond the preview
Go deeper on TCTR20170119001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170119001.